SCHEMBL13745508

SCHEMBL13745508

CC1CCC(CCI)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL862478 0.85
SCHEMBL21258196 0.82 HRH1 (0.36)
SCHEMBL16191111 0.82 CYP1A2 (0.33)
SCHEMBL9406311 0.78 CYP1A2 (0.39)
SCHEMBL9406314 0.78 CYP1A2 (0.39)
SCHEMBL1986118 0.77
SCHEMBL8274293 0.77
SCHEMBL18234215 0.77
SCHEMBL9561918 0.76 CYP1A2 (0.37)
SCHEMBL9561920 0.76 CYP1A2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9708336-B2 Metallo-beta-lactamase inhibitors MERCK SHARP & DOHME CORP. (US) 2017-07-18 US disclosed
US-20160333021-A1 METALLO-BETA-LACTAMASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-11-17 US disclosed
WO-2009097113-A2 OXAZOLE AND THIAZOLE COMPOUNDS AS B-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY (US) 2009-08-06 WO disclosed
EP-1192134-B1 PROCESSES FOR THE PREPARATION OF (R)-G(A)-(2,3-DIMETHOXYPHENYL)-1-(2-(4-FLUOROPHENYL)ETHYL)-4-PIPERIDINEMETHANOL AVENTIS PHARMA INC (US) 2007-09-19 EP disclosed